7.95
price down icon3.99%   -0.33
after-market アフターアワーズ: 7.95
loading

Sage Therapeutics Inc (SAGE) 最新ニュース

pulisher
Mar 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Connect - Markets Insider

Mar 30, 2025
pulisher
Mar 29, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

SAGE THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc.SAGE - The Malaysian Reserve

Mar 28, 2025
pulisher
Mar 28, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Rating of “Hold” by Analysts - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - Markets Insider

Mar 27, 2025
pulisher
Mar 27, 2025

Sage Therapeutics ($SAGE) Failed Drug Launch and Misleading FDA Guidance Case - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

Status Epilepticus Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Marinus Pharma, Pfizer, UCB Biopharma SRL, Sage Therapeutics, Shire - The Globe and Mail

Mar 27, 2025
pulisher
Mar 27, 2025

How To Trade (SAGE) - Stock Traders Daily

Mar 27, 2025
pulisher
Mar 26, 2025

Bank of New York Mellon Corp Has $931,000 Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Investors to Learn More About the Investigation - Markets Insider

Mar 25, 2025
pulisher
Mar 22, 2025

Amundi Invests $166,000 in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Mar 22, 2025
pulisher
Mar 19, 2025

Investors who hold shares of Sage Therapeutics, Inc. (NASDAQ: - openPR.com

Mar 19, 2025
pulisher
Mar 18, 2025

US Bancorp DE Acquires 2,268 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Notice to Long-Term Shareholders of Fluence Energy, Inc. - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc.SAGE - Business Wire

Mar 17, 2025
pulisher
Mar 16, 2025

Sage moved to Underperform at BofA; says Biogen’s buyout impact has passed - MSN

Mar 16, 2025
pulisher
Mar 15, 2025

Attention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on You - The Globe and Mail

Mar 15, 2025
pulisher
Mar 14, 2025

Notice to Long-Term Shareholders of Mercury Systems, Inc. - GlobeNewswire

Mar 14, 2025
pulisher
Mar 14, 2025

Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims - Morningstar

Mar 14, 2025
pulisher
Mar 14, 2025

Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.

Mar 14, 2025
pulisher
Mar 13, 2025

Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Be - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Mar 13, 2025
pulisher
Mar 13, 2025

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Mar 13, 2025
pulisher
Mar 12, 2025

Long-Term Shareholder Notice: Driven Brands Holdings, Inc. - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Sage Therapeutics (NASDAQ:SAGE) Now Covered by Analysts at Bank of America - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Sage Therapeutics stock rated Underperform at BofA (SAGE) - Seeking Alpha

Mar 11, 2025
pulisher
Mar 11, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation - Markets Insider

Mar 11, 2025
pulisher
Mar 10, 2025

Sage Therapeutics resumed with an Underperform at BofA - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Attention Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire

Mar 10, 2025
pulisher
Mar 09, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Investors to Reach Out - Markets Insider

Mar 09, 2025
pulisher
Mar 07, 2025

SAGE Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld Online

Mar 07, 2025
pulisher
Mar 06, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Reach Out - Markets Insider

Mar 06, 2025
pulisher
Mar 05, 2025

Sage’s medical chief is latest leader to leave biotech - The Business Journals

Mar 05, 2025
pulisher
Mar 05, 2025

Sage Therapeutics CMO to leave for new opportunity By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 04, 2025

Sage Therapeutics Announces R&D Leadership Transition - citybiz

Mar 04, 2025
pulisher
Mar 04, 2025

Sage Therapeutics announces CMO resignation By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Sage Therapeutics announces CMO resignation - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

SAGE Therapeutics Announces CMO Resignation and Interim Appointment - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

SAGE Therapeutics Announces Research And Development Leadership Transition -March 04, 2025 at 04:49 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Sage Therapeutics CMO to leave for new opportunity - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

SAGE Therapeutics (SAGE) Announces R&D Leadership Transition - StreetInsider.com

Mar 04, 2025
pulisher
Mar 04, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect - Markets Insider

Mar 04, 2025
pulisher
Mar 04, 2025

Levi & Korsinsky Notifies Sage Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAGE - accessnewswire.com

Mar 04, 2025
pulisher
Mar 03, 2025

Levi & Korsinsky Reminds Sage Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGE - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Sage Therapeutics, Inc. (SAGE): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Mar 01, 2025

Biogen proposes acquisition of partner Sage Therapeutics - MSN

Mar 01, 2025
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):